Acino picks up Cephalon's Mideast, Africa biz; Watson, Noven in Daytrana patent fight;

@FiercePharma: Digesting $13B Nycomed buyout, #Takeda chief says Japanese managers aren't adept at integrating acquisitions - WSJ. Report | Follow @FiercePharma

> Switzerland's Acino has agreed to buy Cephalon's ($CEPH) business in the Middle East and Africa for €80 million, including €60 million in cash. Article

> Watson Pharmaceuticals ($WPI) has asked the FDA to approve its generic version of Noven Pharmaceuticals' ADHD treatment Daytrana. Noven responded by suing for patent infringement. Story

> New York-based drug importer Medisca pleaded guilty to a misdemeanor and admitted it had claimed its unapproved, Chinese-made human growth hormone was cleared by the FDA. Report

> Some Indian patient groups and industry leaders are questioning whether the country's Competition Commission is qualified to police foreign M&A as new proposals would require. News

> Johnson & Johnson ($JNJ) plans to release its third-quarter results Tuesday morning before the market opens. Item

> Apotex got the FDA nod for Ferriprox, its treatment for the iron-related blood disorder thalassemia. Article

> Actavis donated $2.7 million worth of medicines, including heart drugs and anti-infectives, to Libya to help alleviate local shortages. Story

Biotech News 

@FierceBiotech: Twitter opinions linked to vaccine uptake. Item | Follow @FierceBiotech

@JohnCFierce: My first reaction to the Anadys deal? Looks like Roche is figuring that if it's worth anything, they got it cheap. Article | Follow @JohnCFierce

@RyanMFierce: FDA extends halt that began in August on Insmed's trial for inhaled antibiotic. $INSM stock takes hit. Story | Follow @RyanMFierce

@MaureenFierce: Tech needed to stop Twitter from becoming platform for pushers of fake, substandard drugs. Article By @Nick__Taylor. | Follow @MaureenFierce

> Working on a cure, Roche scoops up Anadys hep C drugs in $230M buyout. Article

> Sofinnova bucks a bleak trend with $440M biotech fund. Report

> Harvard project takes aim at improving drug development odds. Item 

Medical Device News

> Boston Sci launches Promus Element stent system in China. Article

> Eucomed to launch conference pre-vetting system. Story

> Analyst names medtech firms ripe for M&A. Report

Biotech IT News

> Google Earth marks sources of infection. Article

> Robot scientist passes big bio test. Story

> Bayer tackles informatics challenges in cancer research. News

> Accelrys brings drug discovery projects to the cloud. Report

> Google VC unit takes lead role DNAnexus's $15M round, hosting huge DNA database. Item

And Finally... To keep counterfeit drugs from setting up a beachhead on Twitter, new filtering technologies are needed, researchers say. Report